ArticleAntibiotics (Basel, Switzerland)2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with
Abstract read
In one paragraph
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
74 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis.Antimicrobial resistance and infection control · 2025Pooled it
- Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy forNutrients · 2022Pooled it
- Prevalence of primaryGut microbes · 2026Review
- Beyond Infection: Mitochondrial Reprogramming and Immunometabolic Adaptation inDiseases (Basel, Switzerland) · 2026Article
- Helicobacter pylori eradication in the face of escalating anti-microbial resistance: Geographic heterogeneity and emerging treatment strategies.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026Review
- Antimicrobial Resistance Patterns and Predictors inMicroorganisms · 2026Article
- Computational design of a multi-epitope vaccine against Helicobacter pylori targeting CagA, FliD, urease, and OipA with cholera toxin B subunit (CTB) adjuvant.BMC microbiology · 2026Article
- Identification of plasmid-mediated quinolone resistance genes inIranian journal of microbiology · 2026Article
- High Levels ofMicroorganisms · 2026Article
- Defining Korean Epidemiologic Cutoffs forGut and liver · 2026Article
- Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection-Questions Focused on Clinical Practice.Alimentary pharmacology & therapeutics · 2026Review
- Establishing Epidemiological Cutoff Values forGut and liver · 2026Article
- Upregulation of innate and adaptive immune mechanisms facilitating prevention of gastricFrontiers in immunology · 2026Article
- Ten-Year Trends in First- and Second-LineJuntendo medical journal · 2026Article
- Extended susceptibility testing for refractory Helicobacter pylori infection: regional testing should guide antimicrobial decision making.BMC infectious diseases · 2025Article
- Effectiveness of First-Line Empirical Treatment in Portugal: Data from the European Registry onGE Portuguese journal of gastroenterology · 2025Article
- Diagnosis, Treatment Patterns and Eradication Success forJGH open : an open access journal of gastroenterology and hepatology · 2025Article
- Molecular Detection of Multiple Antimicrobial Resistance Genes inAntibiotics (Basel, Switzerland) · 2025Article
- Chitosan-based formulations for therapeutic applications. A recent overview.Journal of biomedical science · 2025Review
- Korean Registry on the Current Management ofGut and liver · 2025Article
14 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Luis BujandaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco (UPV/EHU), 20014 San Sebastián, Spain.ORCID 0000-0002-4353-9968
Olga P NyssenCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006 Madrid, Spain.ORCID 0000-0002-4920-9310
Dino VairaDepartment of Surgical and Medical Sciences, University of Bologna, 40138 Bologna, Italy.
Ilaria M SaracinoDepartment of Surgical and Medical Sciences, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0003-4388-7089
Giulia FioriniDepartment of Surgical and Medical Sciences, University of Bologna, 40138 Bologna, Italy.
Frode LerangGastroenterology Unit, Medical Department, Østfold Hospital Trust, 1714 Grålum, Norway.
Sotirios GeorgopoulosGastroenterology Unit, Athens Medical Paleo Faliron Hospital, 17562 Athens, Greece.
Bojan TepesAM DC Rogaska, 3250 Rogaska Slatina, Slovenia.
Frederic HeluwaertGastroenterology Unit, Centre Hospitalier Annecy Genvois, 74370 Pringy, France.
Antonio GasbarriniMedicina Interna, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Roma, Italy.
Theodore RokkasGastroenterology Unit, Henry Dunant Hospital, 11526 Athens, Greece.
Dmitry BordinGastroenterology Unit, A.S. Loginov Moscow Clinical Scientific Center, 111123 Moscow, Russia.ORCID 0000-0003-2815-3992
Sinead SmithGastroenterology Unit, Department of Clinical Medicine, Trinity College Dublin, D24 NR0A Dublin, Ireland.
Vincent LamyCHU de Charleroi, B-6000 Charleroi, Belgium.
María CaldasCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006 Madrid, Spain.ORCID 0000-0002-5017-9913
Elena ResinaCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006 Madrid, Spain.ORCID 0000-0002-7998-8327
Raquel MuñozCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006 Madrid, Spain.
Ángel CosmeCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco (UPV/EHU), 20014 San Sebastián, Spain.
Ignasi PuigAlthaia Xarxa Assistencial Universitària de Manresa and Universitat de Vic-Universitat Central de Catalunya (UVicUCC), 08242 Manresa, Spain.
Francis MegraudUnit INSERM 1053, Université de Bordeaux, 33076 Bordeaux, France.ORCID 0000-0002-2481-1612
Colm O'MorainGastroenterology Unit, Department of Clinical Medicine, Trinity College Dublin, D24 NR0A Dublin, Ireland.
Javier P GisbertCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006 Madrid, Spain.ORCID 0000-0003-2090-3445
The Hp-EuReg Investigators
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
amoxicillinantibiotic resistanceclarithromycinHelicobacter pylorilevofloxacinmetronidazoletetracycline
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.